Urapiidil HCl is an AR (adrenergic α1-AR) antagonist and a SR-1A agonist. Urapidil has an alpha-blocking effect but, unlike other alpha-blockers, also has a central sympatholytic effect mediated via stimulation of SR-1A in the central nervous system.